APO Research
Talk to an analyst

APO RESEARCH · REPORT

Probiotics CDMO Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Probiotics CDMO Service Market Analysis and Forecast 2026-2032

5 June 2026187 pages

Choose your research edition.

Industry ResearchProbiotics CDMO Service Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Probiotics CDMO Service Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Probiotics CDMO Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Probiotics CDMO Service Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Probiotics CDMO Service Market Analysis and Forecast 2026-2032187 pages · $4,950 USD

Market perspective

The global Probiotics CDMO Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Probiotics CDMO Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Probiotics CDMO Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Probiotics CDMO Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Probiotics CDMO Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Probiotics CDMO Service include Lallemand Health Solutions, Biofarma Group, ILDONG Bioscience Co., Ltd., Bioprox Healthcare, Huro Biotech, CKD BiO Corp, Biose Industrie, Rise Therapeutics and Chr. Hansen, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Probiotics CDMO Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Probiotics CDMO Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Probiotics CDMO Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Probiotics CDMO Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Probiotics CDMO Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Probiotics CDMO Service revenue, projected growth trends, production technology, application and end-user industry.

Probiotics CDMO Service Segment by Company

Lallemand Health Solutions

Biofarma Group

ILDONG Bioscience Co., Ltd.

Bioprox Healthcare

Huro Biotech

CKD BiO Corp

Biose Industrie

Rise Therapeutics

Chr. Hansen

Lonza AG

Exden

JuneYao Group (BioGrowing)

Sacco System

Falorni srl

Inpac Probiotics

Glac Biotech Co., Ltd

Probiotics CDMO Service Segment by Type

Oral Dosage Forms (Capsules And Tablets)

Powders and Granules

Liquid Preparations

Probiotics CDMO Service Segment by Application

Medicines and Health Products

Food

Pet Food

Cosmetics

Probiotics CDMO Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Probiotics CDMO Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Probiotics CDMO Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Probiotics CDMO Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Probiotics CDMO Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Probiotics CDMO Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Probiotics CDMO Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Probiotics CDMO Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oral Dosage Forms (Capsules And Tablets) Major Player Table 3. Powders and Granules Major Player Table 4. Liquid Preparations Major Player Table 5. Global Probiotics CDMO Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Medicines and Health Products Major Player Table 7. Food Major Player Table 8. Pet Food Major Player Table 9. Cosmetics Major Player Table 10. Probiotics CDMO Service Industry Trends Table 11. Probiotics CDMO Service Industry Drivers Table 12. Probiotics CDMO Service Industry Opportunities and Challenges Table 13. Probiotics CDMO Service Industry Restraints Table 14. Global Probiotics CDMO Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Probiotics CDMO Service Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Probiotics CDMO Service Market Share by Region (2021-2026) Table 17. Global Probiotics CDMO Service Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Probiotics CDMO Service Market Share by Region (2027-2032) Table 19. Global Probiotics CDMO Service Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Probiotics CDMO Service Revenue Market Share by Players (2021-2026) Table 21. Global Probiotics CDMO Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Probiotics CDMO Service Key Players Headquarters & Area Served Table 23. Global Probiotics CDMO Service Players, Product Type & Application Table 24. Global Probiotics CDMO Service Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Probiotics CDMO Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Probiotics CDMO Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Probiotics CDMO Service Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Probiotics CDMO Service Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Probiotics CDMO Service Revenue Market Share by Type (2021-2026) Table 31. Global Probiotics CDMO Service Revenue Market Share by Type (2027-2032) Table 32. Global Probiotics CDMO Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Probiotics CDMO Service Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Probiotics CDMO Service Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Probiotics CDMO Service Revenue Market Share by Application (2021-2026) Table 36. Global Probiotics CDMO Service Revenue Market Share by Application (2027-2032) Table 37. Lallemand Health Solutions Company Information Table 38. Lallemand Health Solutions Business Overview Table 39. Lallemand Health Solutions Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Lallemand Health Solutions Probiotics CDMO Service Product Portfolio Table 41. Lallemand Health Solutions Recent Development Table 42. Biofarma Group Company Information Table 43. Biofarma Group Business Overview Table 44. Biofarma Group Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Biofarma Group Probiotics CDMO Service Product Portfolio Table 46. Biofarma Group Recent Development Table 47. ILDONG Bioscience Co., Ltd. Company Information Table 48. ILDONG Bioscience Co., Ltd. Business Overview Table 49. ILDONG Bioscience Co., Ltd. Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. ILDONG Bioscience Co., Ltd. Probiotics CDMO Service Product Portfolio Table 51. ILDONG Bioscience Co., Ltd. Recent Development Table 52. Bioprox Healthcare Company Information Table 53. Bioprox Healthcare Business Overview Table 54. Bioprox Healthcare Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Bioprox Healthcare Probiotics CDMO Service Product Portfolio Table 56. Bioprox Healthcare Recent Development Table 57. Huro Biotech Company Information Table 58. Huro Biotech Business Overview Table 59. Huro Biotech Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Huro Biotech Probiotics CDMO Service Product Portfolio Table 61. Huro Biotech Recent Development Table 62. CKD BiO Corp Company Information Table 63. CKD BiO Corp Business Overview Table 64. CKD BiO Corp Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. CKD BiO Corp Probiotics CDMO Service Product Portfolio Table 66. CKD BiO Corp Recent Development Table 67. Biose Industrie Company Information Table 68. Biose Industrie Business Overview Table 69. Biose Industrie Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Biose Industrie Probiotics CDMO Service Product Portfolio Table 71. Biose Industrie Recent Development Table 72. Rise Therapeutics Company Information Table 73. Rise Therapeutics Business Overview Table 74. Rise Therapeutics Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Rise Therapeutics Probiotics CDMO Service Product Portfolio Table 76. Rise Therapeutics Recent Development Table 77. Chr. Hansen Company Information Table 78. Chr. Hansen Business Overview Table 79. Chr. Hansen Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Chr. Hansen Probiotics CDMO Service Product Portfolio Table 81. Chr. Hansen Recent Development Table 82. Lonza AG Company Information Table 83. Lonza AG Business Overview Table 84. Lonza AG Probiotics CDMO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Lonza AG Probiotics CDMO Service Product Portfolio Table 86. Lonza AG Recent Development Table 87. Exden Company Information Table 88. Exden Business Overview Table 89. Exden Probiotics CDMO Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Exden Probiotics CDMO Service Product Portfolio Table 91. Exden Recent Development Table 92. JuneYao Group (BioGrowing) Company Information Table 93. JuneYao Group (BioGrowing) Business Overview Table 94. JuneYao Group (BioGrowing) Probiotics CDMO Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. JuneYao Group (BioGrowing) Probiotics CDMO Service Product Portfolio Table 96. JuneYao Group (BioGrowing) Recent Development Table 97. Sacco System Company Information Table 98. Sacco System Business Overview Table 99. Sacco System Probiotics CDMO Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Sacco System Probiotics CDMO Service Product Portfolio Table 101. Sacco System Recent Development Table 102. Falorni srl Company Information Table 103. Falorni srl Business Overview Table 104. Falorni srl Probiotics CDMO Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. Falorni srl Probiotics CDMO Service Product Portfolio Table 106. Falorni srl Recent Development Table 107. Inpac Probiotics Company Information Table 108. Inpac Probiotics Business Overview Table 109. Inpac Probiotics Probiotics CDMO Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Inpac Probiotics Probiotics CDMO Service Product Portfolio Table 111. Inpac Probiotics Recent Development Table 112. Glac Biotech Co., Ltd Company Information Table 113. Glac Biotech Co., Ltd Business Overview Table 114. Glac Biotech Co., Ltd Probiotics CDMO Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. Glac Biotech Co., Ltd Probiotics CDMO Service Product Portfolio Table 116. Glac Biotech Co., Ltd Recent Development Table 117. North America Probiotics CDMO Service Revenue by Type (2021-2026) & (US$ Million) Table 118. North America Probiotics CDMO Service Revenue by Type (2027-2032) & (US$ Million) Table 119. North America Probiotics CDMO Service Revenue by Application (2021-2026) & (US$ Million) Table 120. North America Probiotics CDMO Service Revenue by Application (2027-2032) & (US$ Million) Table 121. North America Probiotics CDMO Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. North America Probiotics CDMO Service Revenue by Country (2021-2026) & (US$ Million) Table 123. North America Probiotics CDMO Service Revenue by Country (US$ Million) & (2027-2032) Table 124. Europe Probiotics CDMO Service Revenue by Type (2021-2026) & (US$ Million) Table 125. Europe Probiotics CDMO Service Revenue by Type (2027-2032) & (US$ Million) Table 126. Europe Probiotics CDMO Service Revenue by Application (2021-2026) & (US$ Million) Table 127. Europe Probiotics CDMO Service Revenue by Application (2027-2032) & (US$ Million) Table 128. Europe Probiotics CDMO Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. Europe Probiotics CDMO Service Revenue by Country (2021-2026) & (US$ Million) Table 130. Europe Probiotics CDMO Service Revenue by Country (US$ Million) & (2027-2032) Table 131. China Probiotics CDMO Service Revenue by Type (2021-2026) & (US$ Million) Table 132. China Probiotics CDMO Service Revenue by Type (2027-2032) & (US$ Million) Table 133. China Probiotics CDMO Service Revenue by Application (2021-2026) & (US$ Million) Table 134. China Probiotics CDMO Service Revenue by Application (2027-2032) & (US$ Million) Table 135. Asia Probiotics CDMO Service Revenue by Type (2021-2026) & (US$ Million) Table 136. Asia Probiotics CDMO Service Revenue by Type (2027-2032) & (US$ Million) Table 137. Asia Probiotics CDMO Service Revenue by Application (2021-2026) & (US$ Million) Table 138. Asia Probiotics CDMO Service Revenue by Application (2027-2032) & (US$ Million) Table 139. Asia Probiotics CDMO Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 140. Asia Probiotics CDMO Service Revenue by Region (US$ Million) & (2021-2026) Table 141. Asia Probiotics CDMO Service Revenue by Region (US$ Million) & (2027-2032) Table 142. SAMEA Probiotics CDMO Service Revenue by Type (2021-2026) & (US$ Million) Table 143. SAMEA Probiotics CDMO Service Revenue by Type (2027-2032) & (US$ Million) Table 144. SAMEA Probiotics CDMO Service Revenue by Application (2021-2026) & (US$ Million) Table 145. SAMEA Probiotics CDMO Service Revenue by Application (2027-2032) & (US$ Million) Table 146. SAMEA Probiotics CDMO Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. SAMEA Probiotics CDMO Service Revenue by Country (2021-2026) & (US$ Million) Table 148. SAMEA Probiotics CDMO Service Revenue by Country (US$ Million) & (2027-2032) Table 149. Research Programs/Design for This Report Table 150. Authors List of This Report Table 151. Secondary Sources Table 152. Primary Sources List of Figures Figure 1. Probiotics CDMO Service Image Figure 2. Global Probiotics CDMO Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Probiotics CDMO Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oral Dosage Forms (Capsules And Tablets) Image Figure 5. Powders and Granules Image Figure 6. Liquid Preparations Image Figure 7. Global Probiotics CDMO Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Probiotics CDMO Service Market Size Share 2021 VS 2025 VS 2032 Figure 9. Medicines and Health Products Image Figure 10. Food Image Figure 11. Pet Food Image Figure 12. Cosmetics Image Figure 13. Global Probiotics CDMO Service Market Size (US$ Million) & (2021-2032) Figure 14. Global Probiotics CDMO Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Probiotics CDMO Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Probiotics CDMO Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Probiotics CDMO Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Probiotics CDMO Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Probiotics CDMO Service Revenue Market Share by Type (2021-2032) Figure 21. Global Probiotics CDMO Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Probiotics CDMO Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Probiotics CDMO Service Revenue Market Share by Application (2021-2032) Figure 24. North America Probiotics CDMO Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Probiotics CDMO Service Revenue Share by Type (2021-2032) Figure 26. North America Probiotics CDMO Service Revenue Share by Application (2021-2032) Figure 27. North America Probiotics CDMO Service Revenue Share by Country (2021-2032) Figure 28. United States Probiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Probiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Probiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Probiotics CDMO Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Probiotics CDMO Service Revenue Share by Type (2021-2032) Figure 33. Europe Probiotics CDMO Service Revenue Share by Application (2021-2032) Figure 34. Europe Probiotics CDMO Service Revenue Share by Country (2021-2032) Figure 35. Germany Probiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Probiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Probiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Probiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Probiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Probiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Probiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Probiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Probiotics CDMO Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Probiotics CDMO Service Revenue Share by Type (2021-2032) Figure 45. China Probiotics CDMO Service Revenue Share by Application (2021-2032) Figure 46. Asia Probiotics CDMO Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Probiotics CDMO Service Revenue Share by Type (2021-2032) Figure 48. Asia Probiotics CDMO Service Revenue Share by Application (2021-2032) Figure 49. Asia Probiotics CDMO Service Revenue Share by Region (2021-2032) Figure 50. Japan Probiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Probiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Probiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Probiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Probiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Probiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Probiotics CDMO Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Probiotics CDMO Service Revenue Share by Type (2021-2032) Figure 58. SAMEA Probiotics CDMO Service Revenue Share by Application (2021-2032) Figure 59. SAMEA Probiotics CDMO Service Revenue Share by Country (2021-2032) Figure 60. Brazil Probiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Probiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Probiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Probiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Probiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Probiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Probiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Probiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Probiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Probiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Probiotics CDMO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Dosage Forms (Capsules And Tablets)
  • Powders and Granules
  • Liquid Preparations
Applications
  • Medicines and Health Products
  • Food
  • Pet Food
  • Cosmetics
Companies covered
  • Lallemand Health Solutions
  • Biofarma Group
  • ILDONG Bioscience Co., Ltd.
  • Bioprox Healthcare
  • Huro Biotech
  • CKD BiO Corp
  • Biose Industrie
  • Rise Therapeutics
  • Chr. Hansen
  • Lonza AG
  • Exden
  • JuneYao Group (BioGrowing)
  • Sacco System
  • Falorni srl
  • Inpac Probiotics
  • Glac Biotech Co., Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Probiotics CDMO Service Market by Type
  3. 1.2.1 Global Probiotics CDMO Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oral Dosage Forms (Capsules And Tablets)
  5. 1.2.3 Powders and Granules
  6. 1.2.4 Liquid Preparations
  7. 1.3 Probiotics CDMO Service Market by Application
  8. 1.3.1 Global Probiotics CDMO Service Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Medicines and Health Products
  10. 1.3.3 Food
  11. 1.3.4 Pet Food
  12. 1.3.5 Cosmetics
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Probiotics CDMO Service Market Dynamics
  1. 2.1 Probiotics CDMO Service Industry Trends
  2. 2.2 Probiotics CDMO Service Industry Drivers
  3. 2.3 Probiotics CDMO Service Industry Opportunities and Challenges
  4. 2.4 Probiotics CDMO Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Probiotics CDMO Service Market Perspective (2021-2032)
  2. 3.2 Global Probiotics CDMO Service Growth Trends by Region
  3. 3.2.1 Global Probiotics CDMO Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Probiotics CDMO Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Probiotics CDMO Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Probiotics CDMO Service Revenue by Players
  2. 4.1.1 Global Probiotics CDMO Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Probiotics CDMO Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Probiotics CDMO Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Probiotics CDMO Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Probiotics CDMO Service Key Players Headquarters & Area Served
  7. 4.4 Global Probiotics CDMO Service Players, Product Type & Application
  8. 4.5 Global Probiotics CDMO Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Probiotics CDMO Service Market CR5 and HHI
  11. 4.6.3 2025 Probiotics CDMO Service Tier 1, Tier 2, and Tier 3
5 Probiotics CDMO Service Market Size by Type
  1. 5.1 Global Probiotics CDMO Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Probiotics CDMO Service Revenue by Type (2021-2032)
  3. 5.3 Global Probiotics CDMO Service Revenue Market Share by Type (2021-2032)
6 Probiotics CDMO Service Market Size by Application
  1. 6.1 Global Probiotics CDMO Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Probiotics CDMO Service Revenue by Application (2021-2032)
  3. 6.3 Global Probiotics CDMO Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Lallemand Health Solutions
  2. 7.1.1 Lallemand Health Solutions Company Information
  3. 7.1.2 Lallemand Health Solutions Business Overview
  4. 7.1.3 Lallemand Health Solutions Probiotics CDMO Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Lallemand Health Solutions Probiotics CDMO Service Product Portfolio
  6. 7.1.5 Lallemand Health Solutions Recent Developments
  7. 7.2 Biofarma Group
  8. 7.2.1 Biofarma Group Company Information
  9. 7.2.2 Biofarma Group Business Overview
  10. 7.2.3 Biofarma Group Probiotics CDMO Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Biofarma Group Probiotics CDMO Service Product Portfolio
  12. 7.2.5 Biofarma Group Recent Developments
  13. 7.3 ILDONG Bioscience Co., Ltd.
  14. 7.3.1 ILDONG Bioscience Co., Ltd. Company Information
  15. 7.3.2 ILDONG Bioscience Co., Ltd. Business Overview
  16. 7.3.3 ILDONG Bioscience Co., Ltd. Probiotics CDMO Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 ILDONG Bioscience Co., Ltd. Probiotics CDMO Service Product Portfolio
  18. 7.3.5 ILDONG Bioscience Co., Ltd. Recent Developments
  19. 7.4 Bioprox Healthcare
  20. 7.4.1 Bioprox Healthcare Company Information
  21. 7.4.2 Bioprox Healthcare Business Overview
  22. 7.4.3 Bioprox Healthcare Probiotics CDMO Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Bioprox Healthcare Probiotics CDMO Service Product Portfolio
  24. 7.4.5 Bioprox Healthcare Recent Developments
  25. 7.5 Huro Biotech
  26. 7.5.1 Huro Biotech Company Information
  27. 7.5.2 Huro Biotech Business Overview
  28. 7.5.3 Huro Biotech Probiotics CDMO Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Huro Biotech Probiotics CDMO Service Product Portfolio
  30. 7.5.5 Huro Biotech Recent Developments
  31. 7.6 CKD BiO Corp
  32. 7.6.1 CKD BiO Corp Company Information
  33. 7.6.2 CKD BiO Corp Business Overview
  34. 7.6.3 CKD BiO Corp Probiotics CDMO Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 CKD BiO Corp Probiotics CDMO Service Product Portfolio
  36. 7.6.5 CKD BiO Corp Recent Developments
  37. 7.7 Biose Industrie
  38. 7.7.1 Biose Industrie Company Information
  39. 7.7.2 Biose Industrie Business Overview
  40. 7.7.3 Biose Industrie Probiotics CDMO Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Biose Industrie Probiotics CDMO Service Product Portfolio
  42. 7.7.5 Biose Industrie Recent Developments
  43. 7.8 Rise Therapeutics
  44. 7.8.1 Rise Therapeutics Company Information
  45. 7.8.2 Rise Therapeutics Business Overview
  46. 7.8.3 Rise Therapeutics Probiotics CDMO Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Rise Therapeutics Probiotics CDMO Service Product Portfolio
  48. 7.8.5 Rise Therapeutics Recent Developments
  49. 7.9 Chr. Hansen
  50. 7.9.1 Chr. Hansen Company Information
  51. 7.9.2 Chr. Hansen Business Overview
  52. 7.9.3 Chr. Hansen Probiotics CDMO Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Chr. Hansen Probiotics CDMO Service Product Portfolio
  54. 7.9.5 Chr. Hansen Recent Developments
  55. 7.10 Lonza AG
  56. 7.10.1 Lonza AG Company Information
  57. 7.10.2 Lonza AG Business Overview
  58. 7.10.3 Lonza AG Probiotics CDMO Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Lonza AG Probiotics CDMO Service Product Portfolio
  60. 7.10.5 Lonza AG Recent Developments
  61. 7.11 Exden
  62. 7.11.1 Exden Company Information
  63. 7.11.2 Exden Business Overview
  64. 7.11.3 Exden Probiotics CDMO Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Exden Probiotics CDMO Service Product Portfolio
  66. 7.11.5 Exden Recent Developments
  67. 7.12 JuneYao Group (BioGrowing)
  68. 7.12.1 JuneYao Group (BioGrowing) Company Information
  69. 7.12.2 JuneYao Group (BioGrowing) Business Overview
  70. 7.12.3 JuneYao Group (BioGrowing) Probiotics CDMO Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 JuneYao Group (BioGrowing) Probiotics CDMO Service Product Portfolio
  72. 7.12.5 JuneYao Group (BioGrowing) Recent Developments
  73. 7.13 Sacco System
  74. 7.13.1 Sacco System Company Information
  75. 7.13.2 Sacco System Business Overview
  76. 7.13.3 Sacco System Probiotics CDMO Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Sacco System Probiotics CDMO Service Product Portfolio
  78. 7.13.5 Sacco System Recent Developments
  79. 7.14 Falorni srl
  80. 7.14.1 Falorni srl Company Information
  81. 7.14.2 Falorni srl Business Overview
  82. 7.14.3 Falorni srl Probiotics CDMO Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Falorni srl Probiotics CDMO Service Product Portfolio
  84. 7.14.5 Falorni srl Recent Developments
  85. 7.15 Inpac Probiotics
  86. 7.15.1 Inpac Probiotics Company Information
  87. 7.15.2 Inpac Probiotics Business Overview
  88. 7.15.3 Inpac Probiotics Probiotics CDMO Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Inpac Probiotics Probiotics CDMO Service Product Portfolio
  90. 7.15.5 Inpac Probiotics Recent Developments
  91. 7.16 Glac Biotech Co., Ltd
  92. 7.16.1 Glac Biotech Co., Ltd Company Information
  93. 7.16.2 Glac Biotech Co., Ltd Business Overview
  94. 7.16.3 Glac Biotech Co., Ltd Probiotics CDMO Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Glac Biotech Co., Ltd Probiotics CDMO Service Product Portfolio
  96. 7.16.5 Glac Biotech Co., Ltd Recent Developments
8 North America
  1. 8.1 North America Probiotics CDMO Service Revenue (2021-2032)
  2. 8.2 North America Probiotics CDMO Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Probiotics CDMO Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Probiotics CDMO Service Revenue by Type (2027-2032)
  5. 8.3 North America Probiotics CDMO Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Probiotics CDMO Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Probiotics CDMO Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Probiotics CDMO Service Revenue by Application (2027-2032)
  9. 8.5 North America Probiotics CDMO Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Probiotics CDMO Service Revenue by Country
  11. 8.6.1 North America Probiotics CDMO Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Probiotics CDMO Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Probiotics CDMO Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Probiotics CDMO Service Revenue (2021-2032)
  2. 9.2 Europe Probiotics CDMO Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Probiotics CDMO Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Probiotics CDMO Service Revenue by Type (2027-2032)
  5. 9.3 Europe Probiotics CDMO Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Probiotics CDMO Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Probiotics CDMO Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Probiotics CDMO Service Revenue by Application (2027-2032)
  9. 9.5 Europe Probiotics CDMO Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Probiotics CDMO Service Revenue by Country
  11. 9.6.1 Europe Probiotics CDMO Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Probiotics CDMO Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Probiotics CDMO Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Probiotics CDMO Service Revenue (2021-2032)
  2. 10.2 China Probiotics CDMO Service Revenue by Type (2021-2032)
  3. 10.2.1 China Probiotics CDMO Service Revenue by Type (2021-2026)
  4. 10.2.2 China Probiotics CDMO Service Revenue by Type (2027-2032)
  5. 10.3 China Probiotics CDMO Service Revenue Share by Type (2021-2032)
  6. 10.4 China Probiotics CDMO Service Revenue by Application (2021-2032)
  7. 10.4.1 China Probiotics CDMO Service Revenue by Application (2021-2026)
  8. 10.4.2 China Probiotics CDMO Service Revenue by Application (2027-2032)
  9. 10.5 China Probiotics CDMO Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Probiotics CDMO Service Revenue (2021-2032)
  2. 11.2 Asia Probiotics CDMO Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Probiotics CDMO Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Probiotics CDMO Service Revenue by Type (2027-2032)
  5. 11.3 Asia Probiotics CDMO Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Probiotics CDMO Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Probiotics CDMO Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Probiotics CDMO Service Revenue by Application (2027-2032)
  9. 11.5 Asia Probiotics CDMO Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Probiotics CDMO Service Revenue by Country
  11. 11.6.1 Asia Probiotics CDMO Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Probiotics CDMO Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Probiotics CDMO Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Probiotics CDMO Service Revenue (2021-2032)
  2. 12.2 SAMEA Probiotics CDMO Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Probiotics CDMO Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Probiotics CDMO Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Probiotics CDMO Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Probiotics CDMO Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Probiotics CDMO Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Probiotics CDMO Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Probiotics CDMO Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Probiotics CDMO Service Revenue by Country
  11. 12.6.1 SAMEA Probiotics CDMO Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Probiotics CDMO Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Probiotics CDMO Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst